Savara
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
SVRA Key Statistics
Stock Snapshot
The current Savara(SVRA) stock price is $4.96, with a market capitalization of 1.01B. The stock trades at a price-to-earnings (P/E) ratio of -8.79.
During the trading day, Savara(SVRA) stock saw an opening price of $5.05, a peak of —, and a bottom of —.
Trading activity shows a volume of 3.35K, compared to an average daily volume of 1.28M.
Over the past 52 weeks, Savara(SVRA) stock has traded between a high of $7.01 and a low of $1.89.
Over the past 52 weeks, Savara(SVRA) stock has traded between a high of $7.01 and a low of $1.89.
SVRA News
Savara Inc. has reported its first-quarter 2026 results, recording a net loss of US$37.28 million, compared with US$26.64 million a year earlier, and a basic lo...
Savara (SVRA) stock is in focus after the company reported a Q1 2026 net loss of US$37.3 million and highlighted key regulatory milestones and funding plans tie...
“With approximately $203M in cash and, upon MOLBREEVI approval, access to up to an additional $150Min non-dilutive capital through debt and royalty structures,...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.